A public health perspective on a national precision medicine cohort: Balancing long-term knowledge generation with early health benefit

JAMA - Journal of the American Medical Association

Volumn 313, Issue 21, 2015, Pages 2117-2118

  Khoury, Muin J ^b   Evans, James P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; COLORECTAL CANCER; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC MARKER; GENETIC VARIABILITY; GENOMICS; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH EDUCATION; KNOWLEDGE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; SMOKING CESSATION; TIER1 GENE; TIER2 GENE; TUMOR SUPPRESSOR GENE; UNITED STATES; COHORT ANALYSIS; DNA SEQUENCE; GENETIC ASSOCIATION; HUMAN; PERSONALIZED MEDICINE;

COHORT STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDIVIDUALIZED MEDICINE; PUBLIC HEALTH; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84930422966     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.3382     Document Type: Article

References (8)

1. Ashley EA. The precision medicine initiative: a new national effort. JAMA. doi:10.1001/JAMA.2015.3595.
2. Lerman C, Schnoll RA, Hawk LW Jr, et al PGRN-PNAT Research Group. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2015;3(2):131-138.
3. Collins FS. Vision for the Cohort and the Precision Medicine Initiative: February 11, 2015. http://www.nih.gov/precisionmedicine/workshop -presentations/day-1/00-intro-collins.pdf. Accessed February 20, 2015.
4. Dewey FE, Grove ME, Pan C, et al. Clinical interpretation and implications of whole-genome sequencing.JAMA. 2014;311(10):1035-1045.
5. Dotson WD, Douglas MP, Kolor K, et al. Prioritizing genomic applications for action by level of evidence: a horizon-scanning method. Clin Pharmacol Ther. 2014;95(4):394-402.
6. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med. 2011;13(6):499-504.
7. Green RC, Berg JS, Grody WW, et al American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565-574.
8. Khoury MJ. What Gets Measured Gets Done: Genomics, Surveillance Indicators and Healthy People 2020. CDC blog post, 2012. http://blogs.cdc .gov/genomics/2012/09/13/what-gets-measured-gets-done/. Accessed February 25, 2015.